Skip to main content
Sign In

School of Medicine Research Newsroom

The Latest Medical and Research News


Curing Dengue

CU researchers may help scientists develop treatments or vaccines for Dengue fever, West Nile virus, Yellow fever, Japanese encephalitis and other disease-causing flaviviruses.

Q-A - Alzheimers Disease

Huntington Potter, PhD, answers your questions about Alzheimer's Disease.

Zombie Cancer Cells

A cancer cell killed by chemotherapy doesn't necessarily stay dead, CU researchers have learned.

Solving the Sniffles Mystery

CU researchers are closing in on the cause of a common of ailment – the runny nose.

Medical Research Incubator Rises

Bioscience 2 on the Fitzsimons Life Science District will house CU's bioengineering graduate program and startup medical companies.

Strokes Likely to Follow Shingles

Stroke risk is high following a shingles episode, but patients who take antiviral medication have a reduced risk.

Severity of Autism Link

CU researchers have found a segment of DNA that might be linked to the severity of autism.

MS and Marijuana

Marijuana in pill or spray form reduces MS symptoms, and many patients are using it, despite the lack of thorough research.

The Secret to Alligator Ears

A CU researcher says alligators' mysteriously good hearing is the result of air-filled channels connecting the middle ears - a trait similar to that of birds.

Allergy Reactions to Joint Implants

Pain following a joint replacement may be caused by an allergic reaction to materials used in the operation.

Grant for Childhood Stroke Research

Anschutz researchers earned a $3 million grant to study causes and treatment of childhood strokes, which cause lifelong problems.

A Cure for Hep C

A new drug tested at University of Colorado Hospital can cure most patients with Hepatitis C within 12 weeks, researchers say.

Fast-track Drugs Helping Patients

Leukemia patients in clinical trials at Anschutz are taking advantage of life-saving drugs made available by new federal legislation.

Melanoma Therapy Working

A two-drug therapy that blocks separate melanoma growth pathways is helping patients at CU Cancer Center.

Decades-Old Research Trial Keeps Going

A study founded in 1993 with 30,000 participants is helping CU's Barbara Davis Center answer the question: Why do some people get Type 1 diabetes?